Coloplast A/S (CLPBY)

OTC Markets OTCPK Currently down 0.03 (-0.42%) in today's trading session

Track congressional stock trades in Coloplast A/S (CLPBY). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Coloplast A/S is currently trading at $7.11, positioned at 4% of its 52-week range ($6.92 – $11.44). View which politicians have recently bought or sold CLPBY and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$7.11
24h Change
-0.03 (-0.42%)
52 Week Range
$6.92$11.44
View on NASDAQ

Coloplast A/S Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CLPBY

Select to highlight on chart
4 transactions
Compliance: 100%
Josh Gottheimer14 May 202511 Jun 2025SaleStock$1,001 - $15,000N/A (Sale Transaction)
Josh Gottheimer27 Jan 202510 Feb 2025PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)
Josh Gottheimer27 Dec 202414 Jan 2025SaleOptions$1,001 - $15,000N/A (Sale Transaction)
Josh Gottheimer17 May 202408 Jun 2024PurchaseOptions$1,001 - $15,000N/A (Price Data Unavailable)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$15.92B

Volume

47.89K

Beta

0.55

P/E Ratio

26.19

Fundamentals

EPS

$0.27

Div. Yield

5.09%

Open

$7.17

Day Range

$7.06 — $7.17

Company Information

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
OTC · USD
Country
DK
CEO
Lars Soren Rasmussen
IPO Date
2014-01-13

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urolog...

Earnings

Next Report

Q1 2026

12 May

EPS Est.

$0.10

Rev. Est.

$1.1B

Days Until

63

Recent Quarters

Q4 20256 Feb
EPS$0.10
Beat 11.1%
Q3 20254 Nov
EPS$0.07
Miss 26.0%
Q2 202519 Aug
EPS$0.06
Beat 235.2%
Q1 20256 May
EPS$0.06
Beat 333.5%
Q4 20244 Feb
EPS$0.07
Miss 12.5%
Q3 20245 Nov
EPS$0.08
Miss 6.6%
Q2 202420 Aug
EPS$0.08
Miss 8.7%
Q1 20247 May
EPS$0.08
Beat 0.0%
Q4 202328 Feb
EPS$0.08
Beat 0.7%
Q2 202330 Sept
EPS$0.08
Miss 12.2%
Q1 202330 Jun
EPS$0.09
Miss 0.6%
Q4 202231 Mar
EPS$0.08
Miss 10.6%
Q3 202231 Dec
EPS$0.08
Miss 12.1%
Q2 202230 Sept
EPS$0.08
Miss 5.8%
Q1 202230 Jun
EPS$0.09
Beat 5.2%
Q4 202131 Mar
EPS$0.07
Miss 17.1%
Q3 202131 Dec
EPS$0.09
Miss 2.4%
Q2 202130 Sept
EPS$0.10
Q1 202130 Jun
EPS$0.09
Q4 202031 Mar
EPS$0.08
Q3 202031 Dec
EPS$0.09
Q2 202030 Sept
EPS$0.08
Q2 202018 Aug
EPS$4.67
Miss 5.1%
Q1 20206 May
EPS$0.07
Q4 20196 Feb
EPS$5.12
Beat 2.2%
Q3 20195 Nov
EPS$0.08
Q2 201914 Aug
EPS$0.08
Q1 20192 May
EPS$0.07
Q4 20185 Feb
EPS$0.07
Q3 20181 Nov
EPS$0.08
Q2 20188 Aug
EPS$0.07
Q1 20183 May
EPS$4.32
Miss 4.0%
Q4 20171 Feb
EPS$0.07
Q3 20172 Nov
EPS$0.08
Q2 201716 Aug
EPS$4.29
Miss 10.4%
Q1 20173 May
EPS$4.38
Miss 3.3%
Q4 20161 Feb
EPS$0.06
Q3 20162 Nov
EPS$4.75
Miss 0.2%
Q2 201616 Aug
EPS$4.60
Beat 0.4%
Q1 20163 May
EPS$4.31
Miss 0.5%
Q4 20152 Feb
EPS$3.87
Miss 10.0%
Q3 20153 Nov
EPS$4.31
Beat 2.4%
Q2 201511 Aug
EPS$3.35
Miss 10.7%
Q1 20155 May
EPS$3.82
Miss 2.5%
Q4 201429 Jan
EPS$3.74
Miss 5.6%
Q3 201430 Oct
EPS$3.94
Miss 1.3%
Q2 201413 Aug
EPS$3.69
Miss 4.7%
Q1 20147 May
EPS$0.63
Miss 3.1%
Q4 201329 Jan
EPS$0.66
Beat 1.5%
Q2 201330 Sept
EPS$0.06
Q1 201330 Jun
EPS$0.06
Q4 201231 Mar
EPS$0.05
Q3 201231 Dec
EPS$0.05
Q2 201230 Sept
EPS$0.05
Q1 201230 Jun
EPS$0.05
Q4 201131 Mar
EPS$0.04
Q3 201131 Dec
EPS$0.04
Q2 201130 Sept
EPS$0.05
Q1 201130 Jun
EPS$0.04
Q4 201031 Mar
EPS$0.03
Q3 201031 Dec
EPS$0.03
Q2 201030 Sept
EPS$0.03
Q1 201030 Jun
EPS$0.03
Q4 200931 Mar
EPS$0.02
Q3 200931 Dec
EPS$0.02
Q2 200930 Sept
EPS$0.02
Q1 200930 Jun
EPS$0.02
Q4 200831 Mar
EPS$0.02
Q3 200831 Dec
EPS$0.02

2 politicians traded within 30 days

Dividends

Dividend History

8 Dec 2025
Amount $0.1759
16 May 2025
Amount $0.0752
9 Dec 2024
Amount $0.2391
17 May 2024
Amount $0.0720
8 Dec 2023
Amount $0.2330
19 May 2023
Amount $0.0740
2 Dec 2022
Amount $0.2115
13 May 2022
Amount $0.0708
3 Dec 2021
Amount $0.2130
14 May 2021
Amount $0.0810
4 Dec 2020
Amount $0.2114
11 May 2020
Amount $0.0727
6 Dec 2019
Amount $0.1777
6 May 2019
Amount $0.0749
6 Dec 2018
Amount $0.1677
7 May 2018
Amount $0.0795
8 Dec 2017
Amount $0.1653
11 May 2017
Amount $0.0657
5 Dec 2016
Amount $0.1282
19 May 2016
Amount $0.0690
9 Dec 2015
Amount $0.1174
14 May 2015
Amount $0.0671
4 Dec 2014
Amount $0.1246
20 May 2014
Amount $0.0734
6 Dec 2013
Amount $0.1291

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

47
$1001.35-7.04 (-0.70%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$184.77+2.12 (+1.16%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.